Voxel-Based Analysis of Quantitative T1 Maps Demonstrates That Multiple Sclerosis Acts throughout the Normal-Appearing White Matter

References

1. ↵
   Cercignani M, Bozzali M, Iannucci G, et al. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI. J Neurol 2002;249:875–83

   CrossRefPubMedWeb of Science
2. Rovaris M, Bozzali M, Iannucci G, et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch Neurol 2002;59:1406–12

   CrossRefPubMedWeb of Science
3. ↵
   Werring DJ, Clark CA, Barker GJ, et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626–32

   Abstract/FREE Full Text
4. ↵
   Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926–33

   Abstract/FREE Full Text
5. ↵
   Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478–82

   Abstract/FREE Full Text
6. ↵
   Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511–15

   CrossRefPubMedWeb of Science
7. ↵
   Mottershead JP, Schmierer K, Clemence M, et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis: a post-mortem study of the spinal cord. J Neurol 2003;250:1293–301

   CrossRefPubMedWeb of Science
8. Schmierer K, Scaravilli F, Altmann DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407–15

   CrossRefPubMedWeb of Science
9. ↵
   van Waesberghe JH, Kamphorst W, De Groot CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747–54

   CrossRefPubMedWeb of Science
10. ↵
    Ropele S, Strasser-Fuchs S, Augustin M, et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1885–91

    Abstract/FREE Full Text
11. van Walderveen MA, van Schijndel RA, Pouwels PJ, et al. Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. J Magn Reson Imaging 2003;18:656–64

    CrossRefPubMedWeb of Science
12. Parry A, Clare S, Jenkinson M, et al. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis. J Neurol 2002;249:1279–86

    CrossRefPubMedWeb of Science
13. ↵
    Vaithianathar L, Tench CR, Morgan PS, et al. White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis. J Neurol Sci 2002;197:45–50

    CrossRefPubMedWeb of Science
14. ↵
    Griffin CM, Chard DT, Parker GJ, et al. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol 2002;249:193–99

    CrossRefPubMedWeb of Science
15. ↵
    Vaithianathar L, Tench CR, Morgan PS, et al. T1 relaxation time mapping of white matter tracts in multiple sclerosis defined by diffusion tensor imaging. J Neurol 2002;249:1272–78

    CrossRefPubMedWeb of Science
16. ↵
    Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059–69

    Abstract/FREE Full Text
17. ↵
    Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000;11:805–21

    CrossRefPubMedWeb of Science
18. ↵
    Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey: National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–11

    Abstract/FREE Full Text
19. ↵
    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52

    Abstract/FREE Full Text
20. ↵
    Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871–82

    Abstract/FREE Full Text
21. ↵
    Venkatesan R, Lin W, Haacke EM. Accurate determination of spin-density and T1 in the presence of RF-field inhomogeneities and flip-angle miscalibration. Magn Reson Med 1998;40:592–602

    CrossRefPubMedWeb of Science
22. ↵
    Jenkinson M, Bannister P, Brady M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–41

    CrossRefPubMedWeb of Science
23. ↵
    Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89

    CrossRefPubMedWeb of Science
24. ↵
    Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
25. ↵
    Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57

    CrossRefPubMedWeb of Science
26. ↵
    Forman SD, Cohen JD, Fitzgerald M, et al. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med 1995;33:636–47

    CrossRefPubMedWeb of Science
27. Friston KJ, Worsley KJ, Frackowiak RS, et al. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1994;1:210–20

    CrossRefPubMed
28. ↵
    Worsley KJ, Evans AC, Marrett S, et al. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 1992;12:900–18

    CrossRefPubMedWeb of Science
29. ↵
    Filippi M, Iannucci G, Cercignani M, et al. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol 2000;57:1017–21

    CrossRefPubMedWeb of Science
30. ↵
    Steen RG, Schroeder J. Age-related changes in the pediatric brain: proton T1 in healthy children and in children with sickle cell disease. Magn Reson Imaging 2003;21:9–15

    CrossRefPubMedWeb of Science
31. ↵
    Filippi M, Rovaris M, Rocca MA. Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques. Mult Scler 2004;10(suppl 1):S36–S44
32. ↵
    Castriota-Scanderbeg A, Fasano F, Filippi M, et al. T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2004;10:556–61

    Abstract/FREE Full Text
33. ↵
    Pelletier J, Suchet L, Witjas T, et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 2001;58:105–11

    CrossRefPubMedWeb of Science
34. ↵
    Filippi M, Tortorella C, Rovaris M, et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157–61

    Abstract/FREE Full Text
35. Filippi M, Inglese M, Rovaris M, et al. Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study. Neurology 2000;55:940–46

    Abstract/FREE Full Text
36. Kalkers NF, Hintzen RQ, van Waesberghe JH, et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy. J Neurol Sci 2001;184:155–62

    CrossRefPubMedWeb of Science
37. Rovaris M, Bozzali M, Santuccio G, et al. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg Psychiatry 2000;69:723–27

    Abstract/FREE Full Text
38. Rovaris M, Filippi M, Minicucci L, et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000;21:402–08

    Abstract/FREE Full Text
39. Rovaris M, Iannucci G, Falautano M, et al. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci 2002;195:103–09

    CrossRefPubMedWeb of Science
40. ↵
    Traboulsee A, Dehmeshki J, Peters KR, et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler 2003;9:566–73

    Abstract/FREE Full Text
41. ↵
    Wilson M, Morgan PS, Lin X, et al. Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:318–22

    Abstract/FREE Full Text